Heinz Wiendl Selected Research

Heinz Wiendl Research Topics

Disease

143	Multiple Sclerosis 11/2022 - 01/2002
39	Relapsing-Remitting Multiple Sclerosis 01/2022 - 10/2008
33	Inflammation (Inflammations) 01/2021 - 11/2003
21	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2019 - 11/2003
19	Neoplasms (Cancer) 03/2022 - 05/2002
15	Progressive Multifocal Leukoencephalopathy 01/2022 - 02/2011
15	Neuroinflammatory Diseases 01/2022 - 07/2007
13	Infections 04/2022 - 04/2011
11	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 05/2003
11	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 11/2008
9	Disease Progression 05/2022 - 09/2008
9	Myasthenia Gravis 04/2022 - 01/2019
9	Glioma (Gliomas) 01/2020 - 05/2002
8	Demyelinating Diseases (Demyelinating Disease) 12/2021 - 11/2003
7	Deglutition Disorders (Dysphagia) 01/2022 - 01/2019
7	Rheumatoid Arthritis 01/2018 - 08/2007
7	Encephalitis (Encephalitis, Rasmussen) 04/2016 - 07/2006
6	COVID-19 05/2022 - 01/2020
6	Neuromyelitis Optica (Devic's Disease) 05/2022 - 01/2015
6	Ischemic Stroke 01/2020 - 06/2014
6	Stroke (Strokes) 01/2020 - 01/2009
6	Central Nervous System Diseases (CNS Diseases) 01/2017 - 09/2009
6	Rhabdomyosarcoma 11/2008 - 07/2002
5	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 03/2022 - 01/2015
5	Brain Diseases (Brain Disorder) 01/2022 - 06/2015
5	Polymyositis 12/2015 - 07/2002
4	Primary angiitis of the central nervous system 01/2021 - 01/2018
4	Infarction (Infarctions) 01/2020 - 01/2009
4	Autoimmune Diseases of the Nervous System 01/2019 - 04/2016
3	Epilepsy (Aura) 03/2022 - 11/2019
3	Seizures (Absence Seizure) 03/2022 - 07/2019
3	Virus Diseases (Viral Diseases) 02/2022 - 01/2020
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 05/2002
3	Leukocytosis (Pleocytosis) 10/2021 - 11/2005
3	Exanthema (Rash) 08/2021 - 10/2015
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2019
3	HIV Infections (HIV Infection) 10/2020 - 03/2014
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 11/2005
3	Cognitive Dysfunction 11/2019 - 01/2017
3	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2019 - 07/2017
3	Atrophy 01/2019 - 07/2012
3	Necrosis 01/2018 - 01/2002
3	Chronic Progressive Multiple Sclerosis 10/2017 - 11/2005
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 01/2009
3	Brain Ischemia (Cerebral Ischemia) 02/2013 - 01/2010
2	Paraparesis 05/2022 - 02/2021

Drug/Important Bio-Agent (IBA)

35	Natalizumab (Tysabri)FDA Link 01/2022 - 06/2007
25	AntibodiesIBA 04/2022 - 11/2003
25	Alemtuzumab (Campath)FDA Link 01/2022 - 01/2012
20	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2002
18	AntigensIBA 01/2022 - 01/2002
16	Monoclonal AntibodiesIBA 01/2022 - 01/2002
15	CytokinesIBA 12/2018 - 01/2002
15	HLA-G Antigens (HLA G)IBA 01/2017 - 05/2002
11	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 06/2012
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
10	Cladribine FDA LinkGeneric 11/2022 - 01/2002
10	Pharmaceutical PreparationsIBA 01/2022 - 07/2007
10	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021 - 11/2003
10	Potassium Channels (Potassium Channel)IBA 07/2015 - 05/2008
9	Messenger RNA (mRNA)IBA 05/2022 - 05/2002
9	Rituximab (Mabthera)FDA Link 01/2022 - 01/2008
8	AutoantibodiesIBA 03/2022 - 01/2017
8	teriflunomideIBA 01/2022 - 03/2014
8	LigandsIBA 11/2019 - 01/2002
7	Immunoglobulin G (IgG)IBA 01/2022 - 01/2019
6	TabletsIBA 11/2022 - 10/2017
6	Dimethyl FumarateIBA 02/2022 - 02/2016
6	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2006
6	HLA-DR Antigens (HLA-DR)IBA 01/2021 - 05/2003
6	Interferon-betaIBA 09/2015 - 10/2004
5	Protein Isoforms (Isoforms)IBA 03/2022 - 01/2015
5	Integrin alpha4beta1 (VLA-4)IBA 08/2018 - 06/2007
4	VaccinesIBA 05/2022 - 01/2021
4	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2022 - 04/2016
4	HLA Antigens (Human Leukocyte Antigens)IBA 03/2022 - 01/2018
4	ofatumumab FDA Link 01/2022 - 01/2020
4	eculizumab FDA Link 01/2022 - 01/2020
4	ocrelizumabIBA 01/2022 - 01/2021
4	Interferon beta-1a FDA Link 12/2021 - 10/2015
4	InterferonsIBA 12/2021 - 04/2016
4	Intravenous Immunoglobulins (IVIG)FDA Link 08/2021 - 01/2002
4	Cholinergic ReceptorsIBA 05/2021 - 01/2019
4	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2018
4	IntegrinsIBA 01/2019 - 06/2014
4	Daclizumab (Zenapax)FDA Link 01/2019 - 07/2013
4	Glatiramer Acetate (Copaxone)FDA Link 04/2016 - 01/2012
4	Peptides (Polypeptides)IBA 07/2014 - 01/2002
3	Interleukin-2 (IL2)IBA 01/2022 - 07/2013
3	Neuroprotective AgentsIBA 01/2020 - 01/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 01/2002
3	Laminin (Merosin)IBA 08/2018 - 12/2010
3	SaltsIBA 01/2018 - 02/2016
3	EnzymesIBA 01/2018 - 01/2015
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018 - 12/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2016 - 08/2010
3	AcidsIBA 04/2011 - 05/2008
2	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2022 - 01/2022

Therapy/Procedure

69	Therapeutics 01/2022 - 01/2002
13	Immunotherapy 05/2022 - 12/2008